Table 2 Patient demographic profile and baseline disease characteristics
Parameters | Groups | P-Value | |
|---|---|---|---|
Timolol | Placebo | Â | |
(N = 32) | (N = 32) |  | |
Age, Mean (SD) | 53.8 (11.0) | 54.8 (12.4) | 0.735 |
BMI, kg/m2 | 23.1 (2.9) | 22.8 (3.3) | 0.551 |
Coexisting conditions, N (%) | |||
 Hypertension | 4 (12.5) | 3 (9.4 | 0.457 |
 Diabetes mellitus | 5 (15.6) | 7 (21.9) |  |
Dyslipidemia | 6 (18.7) | 7 (21.9) | Â |
 Skin phototype, N (%) | |||
 Type 1 | 0 (0.0) | 0 (0.0) | 0.143 |
 Type 2 | 0 (0.0) | 3 (9.4) |  |
 Type 3 | 19 (59.4) | 21 (65.6) |  |
 Type 4 | 12 (37.5) | 6 (18.7) |  |
 Type 5 | 1 (3.1) | 2 (6.3) |  |
Laterality, N (%) | |||
 Right | 10 (31.0) | 11 12 (34.0) | 0.224 |
 Left | 21(66.0) | 17 (54.0) |  |
 Both | 1 (3.0) | 4 (12.0) |  |
Type of breast surgery, N (%) | |||
 BCS | 28 (87.5) | 29 (90.6) | 0.782 |
 MRM | 4 (12.5) | 3 (9.4) |  |
History of chemotherapy, N (%) | |||
 Yes | 14 (43.7) | 13 (40.6) | 0.800 |
Smoking status, N (%) | |||
 Yes | 0 (0.0) | 1 (3.1) | 0.332 |
Marital status, N (%) | |||
 Single | 2 (6.3) | 2 (6.3) | 1.000 |
 Married | 30 (93.7) | 30 (93.7) |  |
Her2 status | |||
 Positive | 11(34.4) | 14(43.7) |  |
 Hormone receptor status |  |  | 0.442 |
 ER+/PR+ | 19 (59.4) | 22 (68.7) | 0.736 |
 ER+/PR− | 4 (12.5) | 3 (9.4) |  |
 ER−/PR− | 9 (28.1) | 7 (21.9) |  |